Written by
The Sports Network
LOS ANGELES, Calif. (CBS) - Glioblastoma is the deadliest type of brain cancer. Most patients only live about a year after diagnosis.
Now, a new experimental vaccine is giving some hope. UCLA doctors are testing the vaccine which uses the patient's own cancer proteins to teach the body to fight the disease.
Results of the study show patients with the most severe kind of glioblastoma, lived twice the normal 15 months after having surgery and chemotherapy. According to researchers, about 90 percent survived over one year, 75 percent survived two years and 50 percent survived over three years.
The brain cancer vaccine is in phase 2 of trials and won't be available for use outside a study for several years.